Helsinki - Delayed Quote EUR

Bioretec Oy (BRETEC.HE)

Compare
2.3600
0.0000
(0.00%)
At close: January 17 at 5:06:07 PM GMT+2
All All Favorites Text Statistics Technicals Fibonacci Markings Lines
Loading Chart for BRETEC.HE

Recent News: BRETEC.HE

View More
Bioretec signed a new sales and distribution agreement to accelerate the commercialization of RemeOs™ Trauma Screw in the U.S. civilian hospital market

Bioretec signed a new sales and distribution agreement to accelerate the commercialization of RemeOs™ Trauma Screw in the U.S. civilian hospital market
PR Newswire last month
The commercialization of Bioretec's RemeOs™ Trauma Screw in the U.S. proceeds with the signing of new logistics agreement

The commercialization of Bioretec's RemeOs™ Trauma Screw in the U.S. proceeds with the signing of new logistics agreement
PR Newswire last month
Bioretec Ltd's business review January-September 2024: Launch of the RemeOs™ Trauma Screw in the U.S. is proceeding to the next phase, EU authorization in the final stage

Bioretec Ltd's business review January-September 2024: Launch of the RemeOs™ Trauma Screw in the U.S. is proceeding to the next phase, EU authorization in the final stage
PR Newswire 2 months ago
Inside information: Bioretec updates its product development strategy by accelerating the product development of RemeOs™ Spinal Interbody Cage

Inside information: Bioretec updates its product development strategy by accelerating the product development of RemeOs™ Spinal Interbody Cage
PR Newswire 3 months ago
Inside information: Bioretec updates its financial targets

Inside information: Bioretec updates its financial targets
PR Newswire 3 months ago
Bioretec's Shareholders' Nomination Board appointed

Bioretec's Shareholders' Nomination Board appointed
PR Newswire 3 months ago
Bioretec Ltd's half-year report January-June 2024: RemeOs™ trauma screw controlled launch in the U.S. yielded expected positive clinical results

Bioretec Ltd's half-year report January-June 2024: RemeOs™ trauma screw controlled launch in the U.S. yielded expected positive clinical results
PR Newswire 5 months ago
Inside Information: Update for Bioretec's RemeOs™ Trauma Screw European Marketing Authorization

Inside Information: Update for Bioretec's RemeOs™ Trauma Screw European Marketing Authorization
PR Newswire 6 months ago
Bioretec reports successful clinical outcomes from U.S. controlled launch of RemeOs™ trauma screw: fracture healing confirmed in 100% of surgical procedures

Bioretec reports successful clinical outcomes from U.S. controlled launch of RemeOs™ trauma screw: fracture healing confirmed in 100% of surgical procedures
PR Newswire 6 months ago
Inside information: Alan Donze has been appointed as Bioretec's new CEO

Inside information: Alan Donze has been appointed as Bioretec's new CEO
PR Newswire 7 months ago
Bioretec Ltd's business review January-March 2024: Controlled launch in the U.S. progresses

Bioretec Ltd's business review January-March 2024: Controlled launch in the U.S. progresses
PR Newswire 7 months ago
View More

Related Tickers

NXTMH.HE Nexstim Plc
9.12
-1.08%
 
BONEH.HE BBS-Bioactive Bone Substitutes Oyj
0.0666
-0.89%
 
MODU.HE Modulight Oyj
1.0500
+1.94%
 
REG1V.HE Revenio Group Oyj
28.18
+3.00%
 
FNA Paragon 28, Inc.
10.88
+2.06%
 
ECOR electroCore, Inc.
15.90
+1.27%
 
TMDX TransMedics Group, Inc.
57.20
-1.41%